ATP6V1H expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.674600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.696200E-01
Normal-vs-Stage2
9.832000E-01
Normal-vs-Stage3
4.863600E-01
Normal-vs-Stage4
4.595000E-01
Stage1-vs-Stage2
4.868200E-01
Stage1-vs-Stage3
2.258200E-01
Stage1-vs-Stage4
2.381200E-01
Stage2-vs-Stage3
2.773400E-01
Stage2-vs-Stage4
4.907800E-01
Stage3-vs-Stage4
7.395000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.656200E-01
Normal-vs-AfricanAmerican
6.252600E-01
Normal-vs-Asian
9.153800E-01
Caucasian-vs-AfricanAmerican
4.044600E-01
Caucasian-vs-Asian
5.928800E-01
AfricanAmerican-vs-Asian
7.107800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.861200E-01
Normal-vs-Female
8.443200E-01
Male-vs-Female
9.406800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.711400E-01
Normal-vs-Age(41-60Yrs)
5.299600E-01
Normal-vs-Age(61-80Yrs)
9.758200E-01
Normal-vs-Age(81-100Yrs)
7.119400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.752400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.963200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.888200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.428100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.745000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.711000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.706800E-01
Normal-vs-Daily Drinker
9.172400E-01
Normal-vs-Weekly Drinker
7.926200E-01
Normal-vs-Occasional Drinker
6.115200E-01
Normal-vs-Social Drinker
7.927600E-01
Non Drinker-vs-Daily Drinker
4.297000E-01
Non Drinker-vs-Weekly Drinker
9.402400E-01
Non Drinker-vs-Occasional Drinker
8.985800E-02
Non Drinker-vs-Social Drinker
2.957800E-01
Daily Drinker-vs-Weekly Drinker
5.649600E-01
Daily Drinker-vs-Occasional Drinker
4.276000E-01
Daily Drinker-vs-Social Drinker
8.592000E-01
Weekly Drinker-vs-Occasional Drinker
1.856410E-01
Weekly Drinker-vs-Social Drinker
3.806400E-01
Occasional Drinker-vs-Social Drinker
5.192200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.168800E-01
Normal-vs-Grade 2
5.475400E-01
Normal-vs-Grade 3
5.140400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.580600E-01
Grade 1-vs-Grade 3
8.383800E-01
Grade 1-vs-Grade 4
2.168800E-01
Grade 2-vs-Grade 3
3.387200E-01
Grade 2-vs-Grade 4
5.475400E-01
Grade 3-vs-Grade 4
5.140400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.523800E-01
Normal-vs-NonDiabetic
8.410400E-01
Diabetic-vs-NonDiabetic
6.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.007400E-01
Normal-vs-NoPancreatitis
8.600600E-01
Pancreatitis-vs-NoPancreatitis
3.789000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.580400E-01
Normal-vs-N1
9.567000E-01
N0-vs-N1
1.374950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.136200E-01
Normal-vs-TP53-NonMutant
5.739800E-01
TP53-Mutant-vs-TP53-NonMutant
1.842750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
